{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:54:57Z","timestamp":1790898897684,"version":"4.1.0"},"reference-count":44,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education Malaysia","doi-asserted-by":"crossref","award":["FRGS\/1\/2021\/SKK06\/TAYLOR\/02\/1"],"award-info":[{"award-number":["FRGS\/1\/2021\/SKK06\/TAYLOR\/02\/1"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"crossref"}]},{"award":["FRGS\/1\/2021\/SKK06\/TAYLOR\/02\/1"],"award-info":[{"award-number":["FRGS\/1\/2021\/SKK06\/TAYLOR\/02\/1"]}],"id":[{"id":"https:\/\/ror.org\/05mcs2t73","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Office of Knowledge, Transfer and Commercialisation, Research & Enterprise, Taylor\u2019s University","award":["FRGS\/1\/2021\/SKK06\/TAYLOR\/02\/1"],"award-info":[{"award-number":["FRGS\/1\/2021\/SKK06\/TAYLOR\/02\/1"]}]},{"award":["FRGS\/1\/2021\/SKK06\/TAYLOR\/02\/1"],"award-info":[{"award-number":["FRGS\/1\/2021\/SKK06\/TAYLOR\/02\/1"]}],"id":[{"id":"https:\/\/ror.org\/0498pcx51","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Taylor\u2019s University Sdn. Bhd"},{"id":[{"id":"https:\/\/ror.org\/0498pcx51","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>The global rise in multidrug-resistant (MDR) fungal pathogens has positioned Candida auris and Candida glabrata as major threats to public health. In recent years, these pathogens have increasingly been reported beyond traditional hospital settings, including neonatal intensive care units, long-term care facilities, oncology wards, and post-pandemic critical care environments. International surveillance bodies, including the Centers for Disease Control and Prevention (CDC), European Centre for Disease Prevention and Control (ECDC), World Health Organization (WHO), and regional monitoring networks, have documented escalating antifungal resistance, complex outbreak dynamics, and persistent gaps in infection control implementation. C. auris has emerged as a major etiological agent of healthcare-associated outbreaks, particularly in intensive care and neonatal units. Surveillance data indicate that a high proportion of C. auris isolates exhibit resistance to azoles, often exceeding 80% in some regions, while echinocandin resistance remains variable. Resistance patterns have evolved from predominantly azole resistance to broader multidrug-resistant phenotypes, including treatment-emergent echinocandin resistance. Six genetically distinct clades (I\u2013VI) have been identified, with Clades I, III, and IV associated with large-scale outbreaks, whereas available data suggests that Clades II, V, and VI are more geographically restricted, although evidence for the recently described clades remains limited. C. glabrata is increasingly recognized as a major cause of invasive candidiasis, with rising resistance reported across multiple regions. While reduced azole susceptibility was historically predominant, emerging evidence highlights rising dual azole\u2013echinocandin resistance, adaptive microevolution during antifungal therapy, and biofilm-associated tolerance mechanisms. Despite these advances, significant gaps persist in global resistance surveillance and in the mechanistic understanding of virulence and antifungal adaptation. Current mitigation strategies include antifungal stewardship programs, expanded resistance testing, and strengthened surveillance systems. Advances in rapid diagnostic technologies such as matrix-assisted laser desorption ionization\u2013time of flight (MALDI-TOF) mass spectrometry, polymerase chain reaction (PCR)-based assays, and genomic surveillance have improved pathogen identification and outbreak detection, although accessibility remains limited in resource-constrained settings. This review examines emerging epidemiological, genomic, and antifungal resistance trends in C. auris and C. glabrata and highlights key priorities for improving diagnosis, surveillance, stewardship, and management of multidrug-resistant Candida infections.<\/jats:p>","DOI":"10.3390\/jof12060436","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:00:48Z","timestamp":1781535648000},"page":"436","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recent Outbreaks, Resistance Trends, and Control Measures in Candida auris and Candida glabrata Infections"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5679-9038","authenticated-orcid":false,"given":"Sepinoud","family":"Raeisi","sequence":"first","affiliation":[{"name":"School of Medicine, Faculty of Health and Medical Sciences, Taylor\u2019s University, 1 Jalan Taylors, Subang Jaya 47500, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6714-1279","authenticated-orcid":false,"given":"Priya","family":"Madhavan","sequence":"additional","affiliation":[{"name":"School of Medicine, Faculty of Health and Medical Sciences, Taylor\u2019s University, 1 Jalan Taylors, Subang Jaya 47500, Malaysia"},{"name":"Digital Health and Medical Advancement Impact Lab, Taylor\u2019s University, 1 Jalan Taylors, Subang Jaya 47500, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diajeng Sekar","family":"Adisuri","sequence":"additional","affiliation":[{"name":"School of Medicine, Faculty of Health and Medical Sciences, Taylor\u2019s University, 1 Jalan Taylors, Subang Jaya 47500, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/jac\/dkad139","article-title":"Invasive candidiasis: Current clinical challenges and unmet needs in adult populations","volume":"78","author":"Soriano","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/jac\/dkx444","article-title":"Changes in the epidemiological landscape of invasive candidiasis","volume":"73","author":"Lamoth","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","article-title":"Global guideline for the diagnosis and management of candidiasis: An initiative of the ECMM in cooperation with ISHAM and ASM","volume":"25","author":"Cornely","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.4014\/jmb.2404.04040","article-title":"Comprehensive overview of Candida auris: An emerging multidrug-resistant fungal pathogen","volume":"34","author":"Kim","year":"2024","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_5","unstructured":"World Health Organization (WHO) (2022). Fungal Priority Pathogens List to Guide Research, Development and Public Health Action, WHO. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240060241."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Bhargava, A., Klamer, K., Sharma, M., Ortiz, D., and Saravolatz, L. (2025). Candida auris: A continuing threat. Microorganisms, 13.","DOI":"10.3390\/microorganisms13030652"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"De Gaetano, S., Midiri, A., Mancuso, G., Avola, M.G., and Biondo, C. (2024). Candida auris outbreaks: Current status and future perspectives. Microorganisms, 12.","DOI":"10.3390\/microorganisms12050927"},{"key":"ref_8","unstructured":"Centers for Disease Control and Prevention (CDC) (2025, July 10). Infection Control Guidance: Candida auris, Available online: https:\/\/www.cdc.gov\/candida-auris\/hcp\/infection-control\/index.html."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e00570-24","DOI":"10.1128\/aac.00570-24","article-title":"Recent increase in Candida auris frequency in the SENTRY surveillance program: Antifungal activity and genotypic characterization","volume":"68","author":"Castanheira","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2300161","DOI":"10.2807\/1560-7917.ES.2023.28.14.2300161","article-title":"In vivo evolution to echinocandin resistance and increasing clonal heterogeneity in Candida auris during a difficult-to-control hospital outbreak, Italy, 2019 to 2022","volume":"28","author":"Codda","year":"2023","journal-title":"Euro Surveill."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.1038\/s41598-020-63240-z","article-title":"Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait","volume":"10","author":"Ahmad","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Duggan, S., and Usher, J. (2023). Candida glabrata: A powerhouse of resistance. PLoS Pathog., 19.","DOI":"10.1371\/journal.ppat.1011651"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/s42003-022-04087-0","article-title":"Genomic evolution towards azole resistance in Candida glabrata clinical isolates unveils the importance of CgHxt4\/6\/7 in azole accumulation","volume":"5","author":"Galocha","year":"2022","journal-title":"Commun. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"foaf025","DOI":"10.1093\/femsyr\/foaf025","article-title":"Antifungal drug resistance in Candida glabrata: Role of cellular signaling and gene regulatory networks","volume":"25","author":"Naskar","year":"2025","journal-title":"FEMS Yeast Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e00072-24","DOI":"10.1128\/mbio.00072-24","article-title":"Echinocandin persistence directly impacts the evolution of resistance and survival of the pathogenic fungus Candida glabrata","volume":"15","author":"Arastehfar","year":"2024","journal-title":"mBio"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Lin, W., Peng, Y., Xiang, B., Fang, J., Ye, J., and Guo, P. (2025). Prevalence and molecular basis of resistance to echinocandins among clinical Candida glabrata isolates in Guangdong province, China. BMC Microbiol., 25.","DOI":"10.1186\/s12866-025-04275-y"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12281-021-00420-y","article-title":"Candida auris: Diagnostic challenges and emerging opportunities for the clinical microbiology laboratory","volume":"15","author":"Keighley","year":"2021","journal-title":"Curr. Fungal Infect. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-0716-2417-3_2","article-title":"Candida auris identification and profiling by MALDI-TOF mass spectrometry","volume":"2517","author":"Abdolrasouli","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"001820","DOI":"10.1099\/jmm.0.001820","article-title":"The laboratory investigation, management, and infection prevention and control of Candida auris: A narrative review to inform the 2024 national guidance update in England","volume":"73","author":"Jones","year":"2024","journal-title":"J. Med. Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.cmi.2024.03.006","article-title":"New treatment options for critically important WHO fungal priority pathogens","volume":"31","author":"Kriegl","year":"2025","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1146\/annurev-micro-032521-015858","article-title":"Candida auris genetics and emergence","volume":"77","author":"Chowdhary","year":"2023","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1080\/22221751.2022.2125349","article-title":"Confirmation of fifth Candida auris clade by whole genome sequencing","volume":"11","author":"Spruijtenburg","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Byun, S.A., Kwon, Y.J., Lee, G.Y., Choi, M.J., Jeong, S.H., Kim, D., Choi, M.H., Kee, S.-J., Kim, S.H., and Shin, M.G. (2023). Virulence traits and azole resistance in Korean Candida auris isolates. J. Fungi, 9.","DOI":"10.3390\/jof9100979"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3947\/ic.2022.0008","article-title":"Candida auris: An overview of the emerging drug-resistant fungal infection","volume":"54","author":"Sanyaolu","year":"2022","journal-title":"Infect. Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e00842-22","DOI":"10.1128\/mbio.00842-22","article-title":"Genomic diversity across Candida auris clinical isolates shapes rapid development of antifungal resistance in vitro and in vivo","volume":"13","author":"Burrack","year":"2022","journal-title":"mBio"},{"key":"ref_26","unstructured":"Centers for Disease Control and Prevention (CDC) (2025, July 10). Infection Control Actions for Prevention and Response, Available online: https:\/\/www.cdc.gov\/candida-auris\/hcp\/infection-control\/prevention-response.html."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e01140-23","DOI":"10.1128\/jcm.01140-23","article-title":"Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial Candida glabrata isolates","volume":"62","author":"Misas","year":"2024","journal-title":"J. Clin. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e01243-22","DOI":"10.1128\/aac.01243-22","article-title":"Echinocandin resistance in Candida auris occurs in the murine gastrointestinal tract due to FKS1 mutations","volume":"67","author":"Hirayama","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e03526-23","DOI":"10.1128\/spectrum.03526-23","article-title":"Upc2-mediated mechanisms of azole resistance in Candida auris","volume":"12","author":"Li","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e00053-22","DOI":"10.1128\/aac.00053-22","article-title":"Candida auris pan-drug-resistant to four classes of antifungal agents","volume":"66","author":"Jacobs","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e00074-23","DOI":"10.1128\/cmr.00074-23","article-title":"Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease","volume":"37","author":"Hoenigl","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1128\/AAC.48.11.4377-4386.2004","article-title":"Molecular Mechanisms of Primary Resistance to Flucytosine in Candida albicans","volume":"48","author":"Hope","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"102208","DOI":"10.1016\/j.mib.2022.102208","article-title":"The molecular and genetic basis of antifungal resistance in the emerging fungal pathogen Candida auris","volume":"70","author":"Rybak","year":"2022","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cmi.2019.03.028","article-title":"Resistance of Candida to azoles and echinocandins worldwide","volume":"25","author":"Pristov","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1128\/EC.00073-10","article-title":"Genomewide expression profile analysis of the Candida glabrata Pdr1 regulon","volume":"10","author":"Caudle","year":"2011","journal-title":"Eukaryot. Cell"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Cong, P., Wang, B., He, H., Li, X., Peng, L., Liu, J., Guo, H., and Sun, G. (2025). Molecular characterization of Echinocandin resistance and the CHS3-mediated adaptive response in Candida glabrata bloodstream infections in Eastern China. BMC Microbiol., 25.","DOI":"10.1186\/s12866-025-04155-5"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Whaley, S.G., Berkow, E.L., Rybak, J.M., Nishimoto, A.T., Barker, K.S., and Rogers, P.D. (2017). Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.02173"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e00524-24","DOI":"10.1128\/msphere.00524-24","article-title":"Candida glabrata maintains two HAP1 ohnologs, HAP1A and HAP1B, for distinct roles in ergosterol gene regulation to mediate sterol homeostasis under azole and hypoxic conditions","volume":"9","author":"Saha","year":"2024","journal-title":"mSphere"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"S612","DOI":"10.1093\/cid\/civ791","article-title":"Echinocandin resistance in Candida","volume":"61","author":"Perlin","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41467-023-36882-6","article-title":"Macrophage internalization creates a multidrug-tolerant fungal persister reservoir and facilitates the emergence of drug resistance","volume":"14","author":"Arastehfar","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s42770-022-00703-7","article-title":"FLO8 deletion leads to decreased adhesion and virulence with downregulated expression of EPA1, EPA6, and EPA7 in Candida glabrata","volume":"53","author":"Zhao","year":"2022","journal-title":"Braz. J. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jgar.2024.02.012","article-title":"Candida glabrata hospital isolate from Lebanon reveals micafungin resistance associated with increased chitin and resistance to a cell-surface-disrupting agent","volume":"37","author":"Fattouh","year":"2024","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Bal\u00e1zsi, D., T\u00f3th, Z., Locke, J.B., Borman, A.M., Forg\u00e1cs, L., Balla, N., Kov\u00e1cs, F., Kov\u00e1cs, R., Amano, C., and Baran, T.I. (2024). In Vivo Efficacy of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in a Neutropenic Mouse Bloodstream Infection Model. J. Fungi, 10.","DOI":"10.3390\/jof10090617"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/jac\/dkaf124","article-title":"Activity of rezafungin against Candida auris","volume":"80","author":"Locke","year":"2025","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/12\/6\/436\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:43:45Z","timestamp":1781844225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/12\/6\/436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jof12060436"],"URL":"https:\/\/doi.org\/10.3390\/jof12060436","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]}}}